BRIEF-AstraZeneca Says Enhertu Approved In The U.S. For Gastric Cancer

Reuters | Updated: 18-01-2021 13:07 IST | Created: 18-01-2021 12:59 IST
BRIEF-AstraZeneca Says Enhertu Approved In The U.S. For Gastric Cancer
Representative image Image Credit: Twitter (@AstraZeneca)

AstraZeneca PLC:

* ASTRAZENECA PLC - ENHERTU APPROVED IN THE US FOR GASTRIC CANCER

* ASTRAZENECA - ENHERTU APPROVED IN US FOR TREATMENT OF PATIENTS WITH PREVIOUSLY TREATED HER2-POSITIVE ADVANCED GASTRIC CANCER Source text for Eikon: Further company coverage:

TRENDING

1
Lula ahead in polls for Brazil's first-round vote; runoff likely

Lula ahead in polls for Brazil's first-round vote; runoff likely

Global
2
Trump tries to fire up Ohio voters as Republicans defend Senate seat in close race

Trump tries to fire up Ohio voters as Republicans defend Senate seat in clos...

Global
3
Lula ahead in polls for Brazil's first-round vote; runoff likely

Lula ahead in polls for Brazil's first-round vote; runoff likely

Global
4
Latvia PM Kulbergs wins election held under shadow of Ukraine war

Latvia PM Kulbergs wins election held under shadow of Ukraine war

Global

PERSPECTIVES AND INSIGHTS

Better Schools, Stronger Economy: Saudi Arabia Eyes a Major Growth Dividend From Education

Beyond Speed: Peru’s AI Experiment Shows Why Teacher Skills Matter More Than Technology Access

World Bank’s Billion-Person Digital Push Puts Affordable Internet and AI at Center Stage

Africa, Asia and the Americas Face Intensifying Drought Under High-Emission Futures

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026